496
Participants
Start Date
December 25, 2021
Primary Completion Date
June 30, 2024
Study Completion Date
January 31, 2025
Neu2000KWL group
1st infusion of 750mg in patients receiving endovascular therapy within 12 hours following ischemic stroke onset followed by 9 consecutive infusions of 500 mg at intervals of 12 ± 1 hours, twice a day.
Placebo group
1st infusion of the same volume of saline in patients receiving endovascular therapy within 12 hours following ischemic stroke onset followed by 9 consecutive infusions of same volume of saline at intervals of 12 ± 1 hours, twice a day
RECRUITING
Seoul National University Bundang Hospital, Seongnam
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Yongin Severance Hospital, Yŏngin
NOT_YET_RECRUITING
Hallym University Dongtan Sacred Heart hospital, Hwaseong
RECRUITING
Gachon University Gil Medical Center, Incheon
NOT_YET_RECRUITING
Inha University Hospital, Incheon
RECRUITING
Chungbuk National University Hospital, Cheongju-si
RECRUITING
Daejeon Eulji Medical Center, Eulji University, Daejeon
RECRUITING
Kyungpook National University Hospital, Daegu
RECRUITING
Keimyung University Dongsan Medical Center, Daegu
RECRUITING
Ulsan University Hospital, Ulsan
RECRUITING
Inje University Busan Paik Hospital, Busan
RECRUITING
Dong-A University Hospital, Busan
RECRUITING
Gyeongsang National University Hospital, Changwon
NOT_YET_RECRUITING
Wonkwang University Hospital, Iksan
RECRUITING
Jeonbuk National University Hospital, Jeonju
RECRUITING
Chosun University Hospital, Gwangju
RECRUITING
Chonnam National University Hospital, Gwangju
RECRUITING
Jeju National University Hospital, Jeju City
RECRUITING
Kyunghee University Medical Center, Seoul
RECRUITING
Korea University Anam Hospital, Seoul
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Ewha womans University Seoul Hospital, Seoul
Lead Sponsor
GNT Pharma
INDUSTRY